. Imatinib Mesylate Reduces Bone Marrow Fibrosis and Overwhelms the Adverse Prognostic Impact of Reticulin Formation in Patients with Chronic Myeloid Leukemi | AVESİS

Istanbul University Research Information System

. Imatinib Mesylate Reduces Bone Marrow Fibrosis and Overwhelms the Adverse Prognostic Impact of Reticulin Formation in Patients with Chronic Myeloid Leukemi

Copy For Citation

TANRIKULU ŞİMŞEK E., EŞKAZAN A. E., CENGİZ M., AR C., EKİZOĞLU ERATAK S., SALİHOĞLU A., ...More

57th ASH Annual Meeting and Exposition, Orlando, United States Of America, 5 - 08 December 2015

Publication Type: Conference Paper / Full Text
City: Orlando
Country: United States Of America
Istanbul University Affiliated: Yes